The Relationship Between Ebola Virus and Host Factors: Difference between revisions

From MicrobeWiki, the student-edited microbiology resource
No edit summary
No edit summary
Line 10: Line 10:
==Ebola Genome and Replication Cycle==
==Ebola Genome and Replication Cycle==


[[Image: Ebola genome.png|thumb|300px|right|Figure 2: The negative-strand RNA genome of Ebolavirus.
<br> Image source: http://viralzone.expasy.org/all_by_species/207.html [6]]]


==Cathepsin B and Ebolavirus Entry==
==Cathepsin B and Ebolavirus Entry==
Line 41: Line 43:
<br>
<br>


[5] [http://ac.els-cdn.com/S0166354214002034/1-s2.0-S0166354214002034-main.pdf?_tid=d64128bc-6832-11e4-ac8a-00000aab0f26&acdnat=1415553008_944d20c590fb09893a89de4d6a198faf Reid, S.P., Shurtleff, A.C., Costantino, J.A., Tritsch, S.R., Retterer, C., Spurgers, K.B., Bavari, S. <b>2014</b>. HSPA5 is an essential host factor for Ebola virus infection. <i>Antiviral Research</i> 109: 171-174.
[5] [http://ac.els-cdn.com/S0166354214002034/1-s2.0-S0166354214002034-main.pdf?_tid=d64128bc-6832-11e4-ac8a-00000aab0f26&acdnat=1415553008_944d20c590fb09893a89de4d6a198faf Reid, S.P., Shurtleff, A.C., Costantino, J.A., Tritsch, S.R., Retterer, C., Spurgers, K.B., Bavari, S. <b>2014</b>. HSPA5 is an essential host factor for Ebola virus infection. <i>Antiviral Research</i> 109: 171-174.]


<br>
<br>

Revision as of 17:17, 9 November 2014

By: Amanda He (currently being edited)

Introduction to Ebolavirus

Ebolaviruses (EBOV) are enveloped viruses that belong to the Filoviridae family. EBOV has received a significant amount of international attention because it causes severe hemorrhagic fevers in humans with a fatality rate of approximately 60% [1]. A minority of cases with infection results in flu-like symptoms with the addition of mild blood coagulopathy, blood loss, and increase in white blood cells, but these patients have a full recovery. The majority of cases develop severe illness with excessive hemorrhaging and blood clotting, which results in shock and death. However, it is important to note that a major factor of the fatality rate of Ebolavirus disease is the access to proper healthcare. EBOV is extremely infectious and can be transmitted through exposure to bodily fluids such as feces, saliva, urine, vomit, and semen from an infected individual and can enter the body through broken skin or unprotected mucous membrane. For a healthcare worker who may be interacting with a number of different patients, it is important to wear appropriate protective equipment and practice appropriate infection control and sterilization measures [2]. Potentially infected individuals must be isolated from other patients to prevent further outbreaks. Although an individual may be infected, the symptoms are not automatic as the virus has an incubation period ranging from 2 to 21 days [3]. The average incubation period is 7-10 days. Through isolation of a potentially infected individual, it can prevent the spread to others.


Several studies have characterized EBOV infection to disable the immune system and the vascular system. The disabling of the vascular system is what leads to the symptoms such as hemorrhage, hypotension, and blood pressure drop [Ansari]. Autopsy of EBOV infected patients found the viruses located primarily in the endothelial cells, mononuclear phagocytic cells, and several fibroblasts and hepatic sinusoids [3]. As a result, it is likely that the initial infection of EBOV targets macrophages and monocytes [4]. The infection of macrophages and monocytes leads to increased synthesis of tumor necrosis factor-α (TNF-α), which induces fever and lymphoid cell apoptosis [3]. Additionally, infection of macrophages and monocytes can induce the release of various pro-inflammatory proteins.


As of 2014, there are no approved therapeutic strategies to treat infection. As a result, there has been a significant emphasis on studying the host factors EBOV recruits [5]. Host factors are traits found in an individual that could have an effect on their susceptibility to disease. In recent studies, certain host factors such as cathepsin B, heat shock 70 kDa protein 5, and STAT1 have been identified to play a role in EBOV infection. Further investigation of host factors can help grasp a better understanding about EBOV and potentially lead to a treatment.

Ebola Genome and Replication Cycle

File:Ebola genome.png
Figure 2: The negative-strand RNA genome of Ebolavirus.
Image source: http://viralzone.expasy.org/all_by_species/207.html [6]

Cathepsin B and Ebolavirus Entry

HSPA5 and

STAT1 and VP24

Conclusion

References

[1] Adu-Gyamfi, E., Soni, S.P., Jee, C.S., Digman, M.A., Gratton, E., Stahelin, R.V. 2014. A Loop Region in the N-Terminal Domain of Ebola Virus VP40 is important in viral assembly, budding and egress. Viruses. 6: 3837-3854..


[2] Centers for Disease Control and Prevention. 2014. Ebola Virus Disease Prevention.


[3] Ansari, A.A. 2014. Clinical features and pathobiology of Ebolavirus infection. Journal of Autoimmunity. In press.


[4] Slonczewski, J.L. and Foster, J.W. Microbiology: An Evolving Science. "W.W. Norton & Company, Inc." 2013. Third Ed.


[5] Reid, S.P., Shurtleff, A.C., Costantino, J.A., Tritsch, S.R., Retterer, C., Spurgers, K.B., Bavari, S. 2014. HSPA5 is an essential host factor for Ebola virus infection. Antiviral Research 109: 171-174.




Edited by Amanda He of Joan Slonczewski for BIOL 375 Virology, 2014, Kenyon College.